Jason Thompson
Analyst · Jeff Zekauskas from JPMorgan
Thank you, Ben. Good morning, and welcome to Ashland's second quarter fiscal 2013 conference call and webcast. We released results for the quarter ended March 31, 2013, at approximately 6:00 a.m. Eastern Time today, and this presentation should be viewed in conjunction with the earnings release. These results are preliminary until we file our 10-Q. On the call today are Ashland's Chairman and Chief Executive Officer, Jim O'Brien; Lamar Chambers, Senior Vice President and Chief Financial Officer; John Panichella, Senior Vice President and Group Operating Officer responsible for Ashland's Specialty Ingredients and Ashland Water Technologies; and Luis Fernandez-Moreno, Vice President and President of Ashland Water Technologies. As shown on Slide 2, our remarks today will include forward-looking statements, as that term is defined in securities laws. We believe any such statements are based on reasonable assumptions but cannot assure that such expectations will be achieved. Please also note that during this presentation, we will be discussing adjusted results. We believe this will enhance the understanding of our performance by more accurately reflecting our ongoing business. Please turn to Slide 3 for our second quarter highlights. In the March 2013 quarter, we reported earnings of $0.68 per share from continuing operations. When adjusted for key items, EPS was $1.78 as compared to $1.52 in the year ago quarter, a 17% increase from prior year. Sales during the quarter were $2 billion, a 5% decline versus prior year. We continued to see soft volumes in a few geographies, particularly Western Europe. Despite the soft macroeconomic environment, adjusted EBITDA rose 3% to $339 million with EBITDA margin of 17.2%. During the quarter, we strengthened our capital structure by refinancing our debt. We locked in attractive interest rates, extended and better staggered our maturity schedule and put in place investment-grade covenants. We accomplished this while keeping our expected book interest expense for the year unchanged. In addition, we generated $144 million of free cash flow during the quarter, taking us to $174 million through the first 6 months of the year. Slide 4 details our key items. In total, 5 key items had a net unfavorable EPS impact on continuing operations of $1.10 in the second quarter. The first key item is a $2 million after-tax charge, or a negative $0.03 per share, related to an impairment of the in-process research and development acquired with ISP. As part of the initial ISP purchase accounting, values were assigned to a number of R&D projects then in the pipeline. During the quarter, we discontinued one particular project in order to increase focus on higher-return opportunities. The second key item is an $11 million after-tax charge, or a negative $0.13 per share, related to various cost restructuring efforts and integration activities. Roughly 2/3 of this charge is for severance related to the restructuring of the Water Technologies business, which will be described later in the presentation. The remainder is primarily related to the ISP integration. Both the third and the fourth key items are related to the debt restructuring completed during the quarter. The third is a $34 million after-tax cash charge, or a negative $0.43 per share, related to the termination of interest rate swaps on the term loans under our credit facility. The fourth key item is a $32 million after-tax noncash charge, or a negative $0.39 per share, associated with the accelerated amortization of debt expense and similar charges from the previous financing. Lastly, we incurred a net $9 million tax expense, or a negative $0.12 per share, primarily resulting from a foreign tax assessment. In the year ago quarter, 3 key items combined for a net unfavorable impact on earnings of $0.39 per share. To aid in your analysis versus the peer group, Ashland's results included $29 million of intangible amortization expense during the March 2013 quarter. We carry higher than average amortization due to our corporate transformation and prior acquisitions. Without this amortization, earnings would be roughly $0.25 higher or $2.03 per share. Please turn to Slide 5 for Ashland's adjusted results. Ashland's March quarter sales decreased 5% from the prior year to $2 billion. We continued to see weakness in our more commoditized products, including straight guar, solvents and elastomers, with sales falling a combined 20% year-over-year for these products. In total, we experienced continued -- in addition, we experienced continued softness in Europe and Latin America. On a sequential basis, we did see improvement with sales growing 6%. Gross profit as a percent of sales was 28.8%, up 90 basis points compared to a year ago and up 120 basis points sequentially. Selling, general and administrative and research and development expenses, collectively referred to as SG&A, declined 4% year-over-year. EBITDA increased $10 million, or 3%, versus prior year. EBITDA margin increased 140 basis points to 17.2% compared to the year ago period. Now turn to Slide 6 to review our volume trends. This chart shows underlying volume trends on a normalized and rolling 4 quarters basis. By totaling the trailing 4 quarters for each period, we are eliminating seasonality and showing yearly growth. The data have been normalized for acquisitions, divestitures and joint ventures. As shown here, volumes in Specialty Ingredients have declined slightly in recent quarters. This decline is primarily related to the commodity product lines of guar and intermediates and solvents. Performance Materials was negatively affected by a 20% decline in elastomers volumes, driven by weakness in the North American replacement tire market. Water Technologies volumes were slightly ahead of last year. Volumes in Consumer Markets declined as a result of continued softness in the North American DIY market. Now let's turn to Slide 7 for Ashland's overall EBITDA bridge. This chart shows what led to the March quarter's performance as compared with the year ago period. Volume was an $11 million headwind to EBITDA, driven by volume declines in Specialty Ingredients and Performance Materials. Lower margins within Specialty Ingredients, primarily related to guar, offset gains elsewhere. SG&A, which is adjusted for currency translation, contributed $19 million to EBITDA with pension income accounting for roughly 1/3 of this increase. Currency translation and other items represented a $6 million tailwind to EBITDA. All together, the EBITDA increased by $10 million compared to a year ago. Now let's turn to Slide 8. Total liquidity, which is cash plus available revolver and A/R capacity was $1.5 billion at quarter end. The $75 million increase versus the December quarter is due primarily to the larger revolver established as part of the recent refinancing. During the quarter, we paid down $44 million of debt. Our gross debt now stands at $3.5 billion and our net debt is $3 billion. As part of our refinancing, we replaced our previous secured term loans A and B with $2.3 billion worth of unsecured bonds and the forward tranches, with maturities ranging from 3 to 30 years. Rates range from 3% on the 3-year bond, to 6 7/8% on the 30-year issuance. We also replaced our revolver with a $1.2 billion unsecured 5-year facility, reducing the rate 25 basis points. In addition, we essentially doubled the weighted average maturity to almost 10 years and added an investment-grade covenant package. We continue to have more than $400 million of prepayable debt and have another $600 million due in 2016. I'll now turn the presentation over to John Panichella, who will begin with Slide 9.